Team-Based Approaches

By Wayne B. Batchelor, MD, MHS

PE Response Teams: Evolution Within the Revolution

Early adopters of the PERT concept share practical insights on forming an effective team.

Moderator: Rachel P. Rosovsky, MD, MPH;
Panelists: George Davis, PharmD; James Horowitz, MD; Brent Keeling, MD; Vicki McNally, MSN, RN, NP; John Moriarty, MD, FSIR; Soophia Naydenov, MD, FCCP; Fionnuala Ní Áinle, MD, PhD; and Charles B. Ross, MD, FACS, DFSVS

Team Approaches to Hypertension Management: New Opportunities for Interventionalists

A multidisciplinary approach to hypertension is necessary to achieve optimal outcomes, with interventionalists increasingly involved with the reemergence of promising nonpharmacologic options such as renal denervation.

By Klevin Roger L. Reyes, MD; Gizem Bilgili, MD; and Florian Rader, MD, MSc

A New Hope to Heart Failure Treatment: Six Keys to Building a Quaternary Mitral and Tricuspid Center of Excellence

Early adopters of transcatheter mitral and tricuspid therapies share practical insights on creating a quaternary center of excellence.

By Dee Dee Wang, MD, FACC, FASE, FSCCT, FSCAI, and Brian P. O’Neill, MD, FACC

Aortic Stenosis Lifetime Management

Current guidelines support a multidisciplinary heart valve team approach.

By Hooman Bakhshi, MD, and Matthew Sherwood, MD, MHS

Systems of Care Approach to the Management of Cardiogenic Shock

Recent studies have demonstrated the merits of protocoled team-based care with regionalized shock networks in improving outcomes in cardiogenic shock.

By Raghav Gattani, MD; Carolyn M. Rosner, NP, MBA; and Behnam N. Tehrani, MD

Literature Highlights: Evaluating the Role of Multidisciplinary Heart Teams in Cardiovascular Medicine

Dr. Wayne B. Batchelor and colleagues review the history, composition, and challenges of the cardiovascular MDHT and present best practices for its use.

Re-Engineering Cardiology Care Delivery to Meet Growing Demands

The increased need for cardiovascular services should be met with an advancement of the care team and an embrace of virtual and digital care.

By Xiaoyan Huang, MD, FACC; Meredith Rosenthal, PhD; and Joel Sauer, MBA

An Interview With Gorav Ailawadi, MD, MBA

The University of Michigan cardiac surgeon shares why he was drawn to transcatheter interventions, insights from his work at the forefront of device innovation, the role of the surgeon-scientist, and his philosophy for treating patients deemed “too high risk.”

Study Examines In-Hospital and Long-Term Outcomes of CTO PCI and High-Risk Non-CTO PCI

TRILUMINATE Study Demonstrates Safety and Improved QOL Associated With Tricuspid TEER for Severe Tricuspid Regurgitation